Does Ibuprofen Increase Bleed Risk for Pediatric Tonsillectomy?

Peggy Leung1, Elliana Kirsh DeVore2, Kosuke Kawai1,2

  • 1Department of Otolaryngology and Communication Enhancement, Boston Children's Hospital, Boston, Massachusetts, USA.

Insights

Pediatric posttonsillectomy hemorrhage (PTH) risk increased from 2010-2015, particularly with ibuprofen use. Older age, male sex, comorbidities, and certain medications were associated with higher PTH risk.

Area of Science:

  • Pediatric Otolaryngology
  • Surgical Outcomes Research
  • Health Informatics

Background:

  • Posttonsillectomy hemorrhage (PTH) is a significant complication in pediatric patients.
  • Identifying risk factors for PTH and transfusion is crucial for improving patient safety and outcomes.

Purpose of the Study:

  • To identify risk factors associated with pediatric posttonsillectomy hemorrhage (PTH).
  • To evaluate the need for blood transfusion in pediatric patients experiencing PTH.
  • To analyze trends in PTH incidence over time.

Main Methods:

  • Retrospective cohort study utilizing the Pediatric Health Information System (PHIS) database (2004-2015).
  • Inclusion of children aged 18 years or younger undergoing tonsillectomy with or without adenoidectomy (T±A).
  • Evaluation of risk factors including demographics, comorbidities, surgical indications, medications, and year of surgery.

Main Results:

  • A total of 551,137 patients underwent T±A, with 1.58% experiencing PTH.
  • PTH incidence increased from 1.33% in 2010 to 1.91% in 2015 (P < .001).
  • Risk factors for PTH included older age, male sex, medical comorbidities, recurrent tonsillitis, intensive care unit admission, and use of ibuprofen, ketorolac, anticonvulsants, and antidepressants. Blood transfusion was required in 2.1% of PTH cases.

Conclusions:

  • The incidence of pediatric PTH significantly increased between 2011 and 2015.
  • Ibuprofen use was identified as a potential contributing factor to the rising PTH rates.
  • Further evaluation is needed to determine if the observed increase in risk associated with ibuprofen warrants changes in clinical practice.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
286
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
395
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
130
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
8.6K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
320
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
893